Early identification of poor responders to transarterial chemoembolization for hepatocellular carcinoma

Hepatology International

Volumn 5, Issue 4, 2011, Pages 975-984

  Tsai, Ya Ju ^a,b,c   Hsu, Chia Yang ^a,b   Huang, Yi Hsiang ^a   Su, Chien Wei ^a,b   Lin, Han Chieh ^a,b   Lee, Rheun Chuan ^a,b   Chiang, Jen Huey ^a,b   Huo, Teh Ia ^a,b   Lee, Shou Dong ^a,b  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^c UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Barcelona Clinic Liver Cancer (BCLC); Best supportive care; Hepatocellular carcinoma; Total tumor volume; Transarterial chemoembolization

Indexed keywords

ALBUMIN; ALPHA FETOPROTEIN;

ACCURACY; ADVERSE OUTCOME; AGED; ARTICLE; CANCER INVASION; CANCER RISK; CANCER STAGING; CANCER SURVIVAL; CHEMOEMBOLIZATION; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; INTERMETHOD COMPARISON; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PREDICTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SOCIAL SUPPORT; THERAPY EFFECT; TUMOR VOLUME;

EID: 81855185598     PISSN: 19360533     EISSN: 19360541     Source Type: Journal    
DOI: 10.1007/s12072-011-9276-9     Document Type: Article

References (29)

1. M Omata LA Lesmana R Tateishi PJ Chen SM Lin H Yoshida M Kudo JM Lee BI Choi RT Poon S Shiina AL Cheng JD Jia S Obi KH Han W Jafri P Chow SG Lim YK Chawla U Budihusodo RA Gani CR Lesmana TA Putranto YF Liaw SK Sarin 2010 Asian Pacific Association for the Study of the Liver consensus recommendations on hepatocellular carcinoma Hepatol Int 4 439 474 20827404 10.1007/s12072-010-9165- 7
2. MF Yuen JL Hou A Chutaputti Asia Pacific Working Party on Prevention of Hepatocellular Carcinoma 2009 Hepatocellular carcinoma in the Asia pacific region J Gastroenterol Hepatol 24 346 353 19220670 10.1111/j.1440-1746.2009. 05784.x
3. J Bruix JM Llovet 2002 Prognostic prediction and treatment strategy in hepatocellular carcinoma Hepatology 35 519 524 11870363 10.1053/jhep.2002.32089 (Pubitemid 34183954)
4. J Bruix M Sherman 2005 Management of hepatocellular carcinoma Hepatology 42 1208 1236 16250051 10.1002/hep.20933 (Pubitemid 43112690)
5. KH Han JT Lee J Seong 2002 Treatment of non-resectable hepatocellular carcinoma J Gastroenterol Hepatol 17 Suppl 3 s424 s427 12472975 10.1046/j.1440-1746.17.s3.39.x (Pubitemid 35454322)
6. JM Llovet J Bruix 2003 Systematic review of randomized trials for unresectable hepatocellular carcinoma: chemoembolization improves survival Hepatology 37 429 442 12540794 10.1053/jhep.2003.50047 1:CAS:528: DC%2BD3sXhsFeltrg%3D (Pubitemid 36152543)
7. CY Hsu YH Huang JH Chiang HC Lin CW Su PC Lee FY Lee TI Huo SD Lee 2010 Transarterial chemoembolization in patients with hepatocellular carcinoma and renal insufficiency J Clin Gastroenterol 44 e171 e177 20048685
8. CY Hsu YH Huang CW Su HC Lin JH Chiang PC Lee FY Lee TI Huo SD Lee 2010 Renal failure in patients with hepatocellular carcinoma and ascites undergoing transarterial chemoembolization Liver Int 30 77 84 19818004 10.1111/j.1478-3231. 2009.02128.x 1:CAS:528:DC%2BC3cXht1ajsrk%3D
9. K Takayasu S Arii I Ikai M Omata K Okita T Ichida Y Matsuyama Y Nakanuma M Kojiro M Makuuchi Y Yamaoka 2006 Prospective cohort study of transarterial chemoembolization for unresectable hepatocellular carcinoma in 8510 patients Gastroenterology 131 461 469 16890600 10.1053/j.gastro.2006.05.021 1:CAS:528:DC%2BD28XpsFyks7Y%3D (Pubitemid 44142456)
10. J Bruix JM Llovet A Castells X Montana C Bru MC Ayuso R Vilana J Rodes 1998 Transarterial embolization versus symptomatic treatment in patients with advanced hepatocellular carcinoma: Results of a randomized, controlled trial in a single institution Hepatology 27 1578 1583 9620330 10.1002/hep.510270617 1:STN:280:DyaK1c3otFKnsg%3D%3D (Pubitemid 28264682)
11. CLIP Group (Cancer of the Liver Italian Program) Tamoxifen in treatment of hepatocellular carcinoma: a randomised controlled trial. Lancet 1998;352:17-20.
12. A Grieco M Pompili G Caminiti L Miele M Covino B Alfei GL Rapaccini G Gasbarrini 2005 Prognostic factors for survival in patients with early-intermediate hepatocellular carcinoma undergoing non-surgical therapy: comparison of Okuda, CLIP, and BCLC staging systems in a single Italian centre Gut 54 411 418 15710992 10.1136/gut.2004.048124 1:STN:280: DC%2BD2M%2FotFKjsA%3D%3D (Pubitemid 40299100)
13. CY Hsu YH Huang CW Su HC Lin PC Lee CC Loong JH Chiang TI Huo SD Lee 2010 Selecting an optimal staging system for Hepatocellular carcinoma: comparison of 5 currently used prognostic models Cancer 116 3006 3014 20564406 10.1002/cncr.25044
14. YH Huang CH Chen TT Chang SC Chen SY Wang HS Lee PW Lin GT Huang JC Sheu HM Tsai PC Lee GY Chau WY Lui SD Lee JC Wu 2005 Evaluation of predictive value of CLIP Okuda, TNM and JIS staging systems for hepatocellular carcinoma patients undergoing surgery J Gastroenterol Hepatol 20 765 771 15853992 10.1111/j.1440-1746.2005.03746.x (Pubitemid 40733373)
15. CY Hsu YH Huang CY Hsia CW Su HC Lin CC Loong YY Chiou JH Chiang PC Lee TI Huo SD Lee 2010 A new prognostic model for hepatocellular carcinoma based on total tumor volume: the Taipei Integrated Scoring system J Hepatol 53 108 117 20451283 10.1016/j.jhep.2010.01.038
16. J Bruix M Sherman JM Llovet M Beaugrand R Lencioni AK Burroughs E Christensen L Pagliaro M Colombo J Rodes 2001 Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver J Hepatol 35 421 430 11592607 10.1016/S0168-8278(01)00130-1 1:STN:280:DC%2BD3MrksFCmtg%3D%3D (Pubitemid 32844200)
17. BF Grant MC Dufour TC Harford 1988 Epidemiology of alcoholic liver disease Semin Liver Dis 8 12 25 3283941 10.1055/s-2008-1040525 1:STN:280:DyaL1c3gsV2ntg%3D%3D
18. TI Huo YH Huang HC Lin JC Wu JH Chiang PC Lee FY Chang SD Lee 2006 Proposal of a modified Cancer of the Liver Italian Program staging system based on the model for end-stage liver disease for patients with hepatocellular carcinoma undergoing loco-regional therapy Am J Gastroenterol 101 975 982 16573785 10.1111/j.1572-0241.2006.00462.x (Pubitemid 43725310)
19. LO Kikuchi DC Paranagua-Vezozzo AL Chagas ES Mello VA Alves AQ Farias R Pietrobon FJ Carriho 2009 Nodules less than 20 mm and vascular invasion are predictors of survival in small hepatocellular carcinoma J Clin Gastroenterol 43 191 195 19142170 10.1097/MCG.0b013e31817ff199
20. Liver Including Intrahepatic Bile Ducts. In Greene F, Page D, Fleming I, eds. American Joint Committee on Cancer Staging Manual. 6th ed. New York: Springer, 2002;131-144
21. The Cancer of the Liver Italian Program (CLIP) Investigators. Prospective validation of the CLIP score: A new prognostic system for patients with cirrhosis and hepatocellular carcinoma. Hepatology 2000;31:840-845
22. DB Brown WC Chapman RD Cook JR Kerr JE Gould TK Pilgram MD Darcy 2008 Chemoembolization of hepatocellular carcinoma: Patient status at presentation and outcome over 15 years at a single center AJR Am J Roentgenol 190 608 615 18287429 10.2214/AJR.07.2879 (Pubitemid 351304502)
23. Groupe d'Etude et de Traitement du Carcinome Hepatocellulaire A comparison of lipiodol chemoembolization and conservative treatment for unresectable hepatocellular carcinoma. N Engl J Med 1995;332:1256-1261
24. L Llado J Virgili J Figueras C Valls J Dominguez A Rafecas J Torras J Fabregat J Guardiola E Jaurrieta 2000 A prognostic index of the survival of patients with unresectable hepatocellular carcinoma after transcatheter arterial chemoembolization Cancer 88 50 57 10618605 10.1002/(SICI)1097-0142(20000101)88: 1<50::AID-CNCR8>3.0.CO;2-I 1:STN:280:DC%2BD3c%2Fos1Onsg%3D%3D (Pubitemid 30027678)
25. C Toso S Asthana DL Bigam AM Shapiro NM Kneteman 2009 Reassessing selection criteria prior to liver transplantation for hepatocellular carcinoma utilizing the Scientific Registry of Transplant Recipients database Hepatology 49 832 838 19152426 10.1002/hep.22693
26. C Toso J Trotter A Wei DL Bigam S Shah J Lancaster DR Grant PD Greig AM Shapiro NM Kneteman 2008 Total tumor volume predicts risk of recurrence following liver transplantation in patients with hepatocellular carcinoma Liver Transpl 14 1107 1115 18668667 10.1002/lt.21484
27. C Camma V Di Marco G Cabibbo F Latteri L Sandonato P Parisi M Enea M Attanasio M Galia N Alessi A Licata MA Latteri A Craxi 2008 Survival of patients with hepatocellular carcinoma in cirrhosis: a comparison of BCLC, CLIP and GRETCH staging systems Aliment Pharmacol Ther 28 62 75 18373636 10.1111/j.1365-2036.2008.03692.x 1:CAS:528:DC%2BD1cXovFelsbY%3D (Pubitemid 351782806)
28. AO Chan MF Yuen CK Hui WK Tso CL Lai 2002 A prospective study regarding the complications of transcatheter intraarterial lipiodol chemoembolization in patients with hepatocellular carcinoma Cancer 94 1747 1752 11920537 10.1002/cncr.10407 (Pubitemid 34241113)
29. BI Carr P Pancoska RA Branch 2009 Tumor and liver determinants of prognosis in unresectable hepatocellular carcinoma: a large case cohort study Hepatol Int 4 396 405 20305756 10.1007/s12072-009-9157-7